CEO Today USA Awards

109 www.ceotodaymagazine.com CEO Today USAAwards 2017 WISCONSIN MATT JENNINGS Chairman, CEO, and President, Phillips-Medisize Corporation, a Molex Company ABOUT MATT JENNINGS Matt Jennings began his career with Phillips-Medisize Corporation in April 2011, as president and chief executive officer. In 2014, Jennings added chairman of the board to his duties, in conjunction with previous duties as president and CEO. He currently serves on the Board of Directors of Spectrum Plastics Group and Spinal Elements Corporation as an Operating Executive for the private equity firm Kohlberg and Company and is a Board of Director of Angus Chemical owned by the private equity firm Golden Gate Capital. He also serves on the Farmer School Business Advisory Council at Miami University of Ohio and on the CEO Advisory Council for AdvaMed the Association for Advance Medical Device and Technology. He has also served on the Board of Directors for e+CancerCare and OmniGuide. In November 2016 Phillips-Medisize was acquired by Koch Industries and operates as an indirect subsidiary under Molex Corporation. Jennings has over 30 years of senior leadership experience, including President of Teleflex Incorporated North American Medical businesses, 8,000 employees, 12 manufacturing facilities and 2 distribution centers. Prior to his tenure with Teleflex, Jennings was the President & CEO of Bioenterprise Corporation, a bioscience business formation, investment and acceleration company. Jennings began his career with Monsanto Corp. in 1985, and later held numerous corporate leadership positions over a twelve-year period with Baxter International and Allegiance Healthcare, in general management operating roles. Jennings holds a bachelor’s degree in Marketing with a minor in Decision Sciences, from Miami University in Oxford, OH, and a master’s degree in Strategy and Business Development from Michigan State University. FIRM PROFILE Phillips-Medisize, LLC, a Molex company, is a leading global outsource provider of design and manufacturing services to the drug delivery, consumable diagnostics, medical device, and specialty commercial markets. The company has annual sales of under ~$1 billion, headquartered in Hudson, WI, and employs over 5,400 people in 21 production locations throughout the United States, Europe, Mexico and China. Backed by the combined global resources of Molex and its parent company Koch Industries, Phillips-Medisize’s core advantage to customers is the knowledge of its people to integrate design, molding, and automation to drive high-quality manufacturing solutions. For more information, please visit www.phillipsmedisize.com or www.molex.com